Li C L, Xie Y Z, Zhu Y Y, Fu Y Y, Zhang T Y
Department of Facial Plastic and Reconstructive Surgery, ENT institute, Eye & ENT Hospital, NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Mar 7;57(3):338-344. doi: 10.3760/cma.j.cn115330-20211117-00744.
To investigate whether the contralateral normal external auditory canal (EAC) skin graft can maintain the ear canal health after EAC reconstruction in unilateral congenital aural atresia (CAA) cases. A Zelen design randomized controlled study was used to collect unilateral CAA patients for EAC reconstruction prospectively (clinical trial registration number: ChiCTR2000032103). The patients were randomly divided into the control group and the trial group. The trial group used the contralateral normal EAC skin graft group (transplant part of the contralateral normal EAC skin to repair the atresia side for unilateral CAA patients), the control group all used scalp blade thick skin. We observed the EAC health and hearing results of the two groups after EAC reconstruction. A total of 13 cases were enrolled from July 2020 to August 2021. There were eight patients in the trial group, including six males and two females, with an average age of 22.3 years (14-36 years). There were two patients with CAA on the left and six patients on the right. The average follow-up time was 8.8 months (4-14 months). There were five patients in the control group, all cases were male with an average age of 16.2 years (12-20 years). There were four patients with CAA on the left and one patient on the right. The average follow-up time was 7.0 months (2-14 months). In the trial group, eight cases of reconstructed EAC epithelium were healthy, one patient had cicatricial stenosis of EAC opening and lateralization of the tympanic membrane. The other patient had cicatricial stenosis of reconstructed EAC, this case also had scar hyperplasia of the contralateral EAC opening but recovered after soft packing and triamcinolone acetonide injection treatment. The healthy side EAC of the rest trial group had no scarring stenosis or local bone hyperplasia during long-term follow-up. In the control group, one patient was lost to follow-up and the other four patients had dry ears of reconstructed EAC, but easily to form crusts and needed to be cleaned repeatedly, one patient had lateralization of the tympanic membrane, the EAC epithelium was not healthy for long-term follow-up. The incidence of complications related to EAC reconstruction was lower than previous studies (5.55, =0.018), and the average postoperative Air-Bone Gap increased (18.8±10.0)dB. By optimizing the EAC reconstruction technology, the health of the reconstructed EAC is improved compared with the previous study. After active intervention and treatment, there should be no scarring stenosis or local bone hyperplasia on the contralateral side EAC.
探讨在单侧先天性外耳道闭锁(CAA)病例中,对侧正常外耳道(EAC)皮肤移植在EAC重建术后能否维持耳道健康。采用Zelen设计的随机对照研究,前瞻性收集行EAC重建的单侧CAA患者(临床试验注册号:ChiCTR2000032103)。患者被随机分为对照组和试验组。试验组采用对侧正常EAC皮肤移植组(将对侧正常EAC皮肤的一部分移植到患侧,修复单侧CAA患者的闭锁侧),对照组均采用头皮刃厚皮。观察两组EAC重建术后的耳道健康情况及听力结果。2020年7月至2021年8月共纳入13例患者。试验组8例患者,其中男性6例,女性2例,平均年龄22.3岁(14 - 36岁)。左侧CAA患者2例,右侧6例。平均随访时间8.8个月(4 - 14个月)。对照组5例患者,均为男性,平均年龄16.2岁(12 - 20岁)。左侧CAA患者4例,右侧1例。平均随访时间7.0个月(2 - 14个月)。试验组中,8例重建EAC上皮健康,1例患者EAC开口瘢痕狭窄及鼓膜内陷。另1例患者重建EAC瘢痕狭窄,该病例对侧EAC开口也有瘢痕增生,但经软填塞及曲安奈德注射治疗后恢复。试验组其余患者的健侧EAC在长期随访中无瘢痕狭窄或局部骨质增生。对照组中,1例患者失访,其余4例患者重建EAC干耳,但易形成痂皮,需反复清理,1例患者鼓膜内陷,长期随访EAC上皮不健康。EAC重建相关并发症的发生率低于以往研究(5.55,P = 0.018),术后平均气骨导差增加(18.8±10.0)dB。通过优化EAC重建技术,与以往研究相比,重建EAC的健康状况得到改善。经过积极干预和治疗,对侧EAC不应出现瘢痕狭窄或局部骨质增生。